Astera Labs (NASDAQ:ALAB) COO Sanjay Gajendra Sells 91,441 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) COO Sanjay Gajendra sold 91,441 shares of the firm’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Sanjay Gajendra also recently made the following trade(s):

• On Thursday, August 7th, Sanjay Gajendra sold 280,000 shares of Astera Labs stock. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00.
• On Wednesday, July 9th, Sanjay Gajendra sold 165,000 shares of Astera Labs stock. The shares were sold at an average price of $98.61, for a total value of $16,270,650.00.
• On Wednesday, June 18th, Sanjay Gajendra sold 76,373 shares of Astera Labs stock. The stock was sold at an average price of $98.39, for a total value of $7,514,339.47.
• On Wednesday, June 4th, Sanjay Gajendra sold 88,627 shares of Astera Labs stock. The stock was sold at an average price of $98.11, for a total value of $8,695,194.97.
• On Tuesday, May 27th, Sanjay Gajendra sold 165,000 shares of Astera Labs stock. The shares were sold at an average price of $98.25, for a total value of $16,211,250.00.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $172.45 on Thursday. The stock’s 50-day simple moving average is $120.52 and its two-hundred day simple moving average is $91.84. The stock has a market capitalization of $28.66 billion, a price-to-earnings ratio of 307.95, a PEG ratio of 4.34 and a beta of 1.39. Astera Labs, Inc. has a 52-week low of $36.85 and a 52-week high of $199.47.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business’s revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ALAB. Susquehanna lifted their price target on shares of Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a research note on Thursday, August 7th. Barclays reiterated an “overweight” rating and set a $155.00 target price (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Zacks Research upgraded Astera Labs to a “strong-buy” rating in a research report on Tuesday, August 12th. Morgan Stanley raised their price objective on Astera Labs from $125.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 6th. Finally, Jefferies Financial Group lifted their price objective on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $129.13.

Hedge Funds Weigh In On Astera Labs

Large investors have recently made changes to their positions in the business. Alliancebernstein L.P. lifted its holdings in Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares in the last quarter. Atreides Management LP raised its position in shares of Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after buying an additional 2,815,614 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after buying an additional 2,751,747 shares in the last quarter. Lord Abbett & CO. LLC boosted its position in shares of Astera Labs by 318.9% during the fourth quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company’s stock worth $240,873,000 after acquiring an additional 1,384,498 shares during the last quarter. Finally, Driehaus Capital Management LLC boosted its position in shares of Astera Labs by 16,640.4% during the fourth quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company’s stock worth $175,408,000 after acquiring an additional 1,316,419 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.